Codeine use and harms in Australia: evaluating the effects of re-scheduling

R. CAIRNS ; A. L. SCHAFFER ; J. A. BROWN ; S. A. PEARSON ; N. A. BUCKLEY | 2020
Dans Addiction (Vol.115, n°3, March 2020) Article : Périodique

BACKGROUND AND AIMS: Globally, codeine is the most-used opioid. In December 2016, Australia announced that low-strength codeine (

Plus d'info

Ajouter à la sélection

Lien externe

Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries

R. BADE ; D. NADARAJAN ; W. HALL ; J. A. BROWN ; NPS Wastewater Consortium ; J. SCHUMANN | 2025
Dans Addiction (Vol.120, n°9, September 2025) Article : Périodique

BACKGROUND AND AIMS: The use of new synthetic opioids, such as the highly potent 2-benzylbenzimidazoles (i.e. nitazene) drugs, is a global health concern because of their increased risk of fatal overdose. In the early 2020s, nitazene analogues w[...]

Plus d'info

Ajouter à la sélection

Lien externe

Nouveauté

The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre

R. CAIRNS ; J. A. BROWN ; N. GUNJA ; N. A. BUCKLEY | 2017
Dans International Journal of Drug Policy (Vol.43, May 2017) Article : Périodique

Background: The emergence of new psychoactive substances (NPS), including synthetic cannabinoid receptor agonists (SCRAs) poses novel challenges for drug regulation and public health. Misconceptions of safety and legality, coupled with the fact [...]

Plus d'info

Ajouter à la sélection